China NMPA Drug Inspection - Hebei Shunquanlong Pharmaceutical Co., Ltd. - rush
China NMPA drug inspection for Hebei Shunquanlong Pharmaceutical Co., Ltd. published September 29, 2021. Drug: rush. The Hebei Provincial Drug Administration issued Drug Quality Bulletin No. 2 on September 29, 2021, detailing results fro
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Hebei Shunquanlong Pharmaceutical Co., Ltd. published September 29, 2021. Drug: rush. The Hebei Provincial Drug Administration issued Drug Quality Bulletin No. 2 on September 29, 2021, detailing results fro
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox